Tagged with OP

Malaysia Billy Urudra, president of the Malaysian Organisation of Pharmaceutical Industries, highlights the major trends and challenges in the Malaysian pharmaceutical industry, especially for generics players and touches upon the potential changes that will arise from the new government.   Can you provide our readers with an overview of the current…

Innovation Richie Etwaru is founder and CEO of Hu-manity, whose vision is to empower people to take ownership of their inherent human data.   The pharmaceutical industry has never seen the full end-to-end benefits of a world where explicitly consented data is available. And this can happen without disruption. Everyone can indeed…

France Jacques Vernin, president of FACOPHAR Santé – the French association representing companies involved in the natural and herbal health space, explains its role and the future of the organization in participating in social dialogue, shaping regulations and promoting French excellence in the field of herbal ingredients.   Could you please…

Hong Kong Yvette Chu, general manager of CooperVision Hong Kong, shares the affiliate’s double-digit growth over the past three years, the importance of their relationships with the optometrists in Hong Kong, the value of their innovative and comprehensive portfolio of contact lenses, and her vision for the affiliate in the next few…

Europe European countries ranked by the levels of generics penetration within their domestic markets. Poland comes out on top by this measurement, with generic medicines making up a full 60.4% of market sales value, followed closely by Russia and Italy. At the other end of the scale, generics make up just…

Cannabis The opioid epidemic has reached new heights of late, claiming an estimated 40,000 American lives every year. The highly addictive nature of opium-derived medicine is the cause of the rising number of overdoses in the US and Canada. There are companies out there that are working to manufacture a new…

Innovation Axel Schumacher, co-founder and Chief Scientific Officer of Shivom, highlights the need for Big Pharma to adopt new technology. Of course, we know that pharma is often innovation-averse. The healthcare industry has been full of disruptions in the last decade, ranging from the explosive growth of medical devices and the…

Innovation Meghann Chilcott, Senior Vice President of OrderInsite, discusses the changing role of pharmacists and technicians.   Patients are consumers, and they expect more from pharmacies than a collection of pill bottles. Local pharmacists have seen their roles continually change over recent years due to enhanced technology that allows them better…

Europe At last week’s European Health Forum Gastein (EHFG), the theme surrounded the United Nations Sustainable Development Goals (SDGs) for 2030. Out of the 17 SDGs, 12 are in some way connected to health and nutrition. In attendance were key stakeholders in European health including Martin Seychell, deputy director of health…

China Professor Richard Barker, founder of New Medicine Partners reflects on China’s very different approach to the biopharma industry.   Napoleon once said: “China is a sleeping giant. Let her sleep, for when she wakes she will shake the world.” Well, in biotech, she is now wide awake I’ve recently returned from…

Innovation Article contributed by Carla Smith, Executive Vice President of The Healthcare Information and Management Systems Society (HIMSS) for PharmaBoardroom. We must assertively bend the arc of technology towards our patients, clinicians, researchers, and caregivers, and re-humanise the health system. One of the many ways patients are de-humanized in a health…

Spain Ana Fernández of Théa Spain discusses the strategic importance of the Spanish affiliate – the group’s oldest, current trends in Spanish ophthalmology, and what differentiates Théa – as a family-run mid-sized company – from its competitors.   Having taken on your first country manager position in January 2018, what are…